Posted 29th March 2019 by Joshua Broomfield
Günter Welz is part of the Open Innovation and Strategic Partnerships department at Bayer. He scouts for and builds relationships with external innovators in academia and business to enrich Bayer’s R&D pipeline, using various tools like the Open Innovation website and the venture capital arm.
Posted 20th August 2018 by Jane Williams
Degrading soil quality and increased interest in sustainable farming have caused the biostimulant market to go from strength-to-strength and it is expected to reach $4.14 billion by 2025.  Despite this, companies have expressed concerns that the regulation of biostimulants will hinder industry growth and the longevity of small companies and start-ups.
We spoke to Nick Moon, Global Regulatory Manager, Plant Impact, to discuss the regulation of biostimulants and its impact on industry.
Posted 10th August 2018 by Jane Williams
At the Partnerships in Biocontrol, Biostimulants, & Microbiome: Europe, Peter Jens, Director of Strategic Alliances at Koppert Biological Systems and CEO of AND Biopharma, discussed regulation from product to systems thinking.
He focused specifically on the way in which consumers and citizens have become more vocal on the quality of products, arguing that the current regulatory discussion is fated and different thinking is required.
Here, he explains what he means by ‘different’ kinds of thinking and how this could help unravel the regulatory quagmire of agrochemicals and agrobiologicals.
Posted 16th July 2018 by Jane Williams
In the final instalment in our series of articles focusing on biopesticide product development, we will be discussing the importance of selecting a formulation type and package size, preferred packaging options, crop specific economics, tank mixability, and tank mixes.
Posted 2nd July 2018 by Jane Williams
Over the past thirty years, Donald R. Marvin, President and CEO of Concentric, has established an impressive track record for building exceptional value for stakeholders at several life science and agri-food companies. Formerly New Jersey’s CFO of the year, he has raised over $350 million in both private and public financing and completed nearly a dozen M&A transactions for his former companies.
Posted 7th May 2018 by Jane Williams
The application of crop biotechnology in agriculture has permitted an enhanced level of income to farmers and environmental benefits, while also reducing cropland expansion. Insect-protected crops, such as corn, showed more than 10% increase in yield worldwide and insect-protected corn and cotton augmented farm income by >$56 billion between 1996 and 2001.
There are important factors to consider to ensure the value and the benefits of these products. These relate to their mode of delivery from suppliers to end users, including correct shipping, storage as well as user education.
Posted 18th April 2018 by Jane Williams
Our vision of the Second Green Revolution goes beyond genetics, synthetic fertilizers, and chemical controls. It is a more holistic approach that integrates biologicals to optimize agriculture in a way that balances the immediate need for high yields and the long-term considerations for soil health.
Posted 13th April 2018 by Jane Williams
2017 was a big year for the AgTech industry, with a record $10.1 billion in investments and an increase of 29% from 2016. Looking forward, we decided to put together a list of 119 top AgTech start-ups and investors.
In this article, we’ll be talking through the results that were gathered from the report, which you can view here.
Whether you’re looking for an investor from seed to series or you’re just interested in the market, you are sure to find this resource useful.